Abstract
In a previous study, we performed a meta-analysis of the oncological outcomes of patients suffering from cervical esophageal squamous cell carcinoma treated with definitive chemoradiotherapy. Further analysis was performed, and a random effect modeling showed a pooled local–regional failure rate of 41.4% (95% CI 32.2–50.8), and a pooled distant failure rate of 21.6% (95% CI 17.0–26.5). The included studies used a median radiotherapy (RT) dose of 61.2 Gy (95% CI 60.0–62.0, range 56.0–66.0), but we measured a non-significant impact of the RT dose on the pooled overall survival (OS), suggesting that an increased RT dose might not be related to an improved OS (p = 0.23). Further research should be conducted to define predictors and prognostic categories that may select the best treatment option for each patient.
References
De Virgilio A, Costantino A, Festa BM, Mercante G, Franceschini D, Franzese C, Scorsetti M, Marrari A, Cavina R, Marano S et al (2022) Oncological outcomes of squamous cell carcinoma of the cervical esophagus treated with definitive (chemo-)radiotherapy: a systematic review and meta-analysis. J Cancer Res Clin Oncol. https://doi.org/10.1007/s00432-022-03965-8
Hoeben A, Polak J, Van De Voorde L, Hoebers F, Grabsch HI, de Vos-Geelen J (2016) Cervical esophageal cancer: a gap in cancer knowledge. Ann Oncol 27:1664–1674. https://doi.org/10.1093/annonc/mdw183
Hulshof MCCM, Geijsen ED, Rozema T, Oppedijk V, Buijsen J, Neelis KJ, Nuyttens JJME, van der Sangen MJC, Jeene PM, Reinders JG et al (2021) Randomized study on dose escalation in definitive chemoradiation for patients with locally advanced esophageal cancer (ARTDECO Study). J Clin Oncol 39:2816–2824. https://doi.org/10.1200/JCO.20.03697
Markar SR, Karthikesalingam A, Penna M, Low DE (2014) Assessment of short-term clinical outcomes following salvage esophagectomy for the treatment of esophageal malignancy: systematic review and pooled analysis. Ann Surg Oncol 21:922–931. https://doi.org/10.1245/s10434-013-3364-0
National Comprehensive Cancer Network (2022) Esophageal and esophagogastric junction cancers (version 2.2022). J Natl Compr Canc Netw. https://doi.org/10.6004/jnccn.2011.0072. https://www.nccn.org/professionals/physician_gls/pdf/esophageal.pdf
Schieman C, Wigle DA, Deschamps C, Nichols FC, Cassivi SD, Shen KR, Allen MS (2013) Salvage resections for recurrent or persistent cancer of the proximal esophagus after chemoradiotherapy. Ann Thorac Surg 95:459–463. https://doi.org/10.1016/j.athoracsur.2012.10.028
Funding
None.
Author information
Authors and Affiliations
Contributions
ADV: study concept and design, manuscript development, review of final manuscript. AC: study concept and design, data analysis, manuscript development, review of final manuscript. BMF: data collection, manuscript development. GM: study design, review of final manuscript. DF: data collection, review of final manuscript. CF: study design, review of final manuscript. MS: supervision, review of final manuscript. AM: data collection, review of final manuscript. RC: study design, review of final manuscript. SM: data collection, review of final manuscript. CC: supervision, review of final manuscript. GS: supervision, manuscript development, review of final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
De Virgilio, A., Costantino, A., Festa, B.M. et al. Reply to Letter to the Editor regarding “Oncological outcomes of squamous cell carcinoma of the cervical esophagus treated with definitive (chemo‐)radiotherapy: a systematic review and meta‐analysis”. J Cancer Res Clin Oncol 149, 1369–1371 (2023). https://doi.org/10.1007/s00432-022-04441-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-022-04441-z